Physician
Hematology
Dr. Robin T. Zon, MD
|
|
Give Review
Robin practices Hematology. She went to Indiana University School of Medicine. Indiana University School of Medicine has a rank of 45 in research and a 47 in primary care She over the years received 1 awards: "Fellow (FACP)". Dr. Robin T. Zon is a published MD as well. She has 33 publications published. The latest was: Management strategies and outcomes of germ cell tumor patients with very high human chorionic gonadotropin levels. She is registered with Medicare.
Publications
- Phase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies: HOG LUN 07-130.
- The changing face of research in community practice.
- A phase II study of combined VEGF inhibitor (bevacizumab+sorafenib) in patients with metastatic breast Cancer: Hoosier Oncology Group Study BRE06-109.
- Achieving Exemplary Attributes With AccrualNet.
- A phase III randomized, double-blind, placebo-controlled study of pilocarpine for vaginal dryness: North Central Cancer Treatment group study N04CA.
- The clinical research team.
- Phase II Trial of Cisplatin, Gemcitabine, and Bevacizumab As First-Line Therapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU 04-75.
- The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for Cancer: a phase III randomized, placebo-controlled, double-...
- Part 2: implementing clinical trials: a review of the attributes of exemplary clinical trial sites.
- Implementing clinical trials: a review of the attributes of exemplary clinical trial sites.
- Breast Cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians.
- American Society of Clinical Oncology provisional clinical opinion: Chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for trea...
- ASCO Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases.
- Commentary: timing is everything.
- National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009.
- A phase II study of pemetrexed as second-line chemotherapy for the treatment of metastatic castrate-resistant prostate Cancer (CRPC); Hoosier Oncology Group GU03-67.
- Intrinsic subtype-associated changes in the plasma proteome in breast Cancer.
- NIH state-of-the-science conference statement: diagnosis and management of ductal Carcinoma in situ (DCIS).
- Use of 5alpha-reductase inhibitors for prostate Cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Gu...
- Use of 5-alpha-reductase inhibitors for prostate Cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice G...
- American Society of Clinical Oncology policy statement: the role of the oncologist in Cancer prevention and risk assessment.
- A phase II study of oral enzastaurin in patients with metastatic breast Cancer previously treated with an anthracycline and a taxane containing regimen.
- American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.
- Hoosier Oncology Group randomized phase II study of docetaxel, vinorelbine, and estramustine in combination in hormone-refractory prostate Cancer with pharmacogenetic ...
- Clinical Research in Private Practice: Q&A With Robin T. Zon, MD, FACP.
- Combined anti-microtubule therapy: a phase II study of weekly docetaxel plus estramustine in patients with metastatic breast Cancer.
- Altretamine for the treatment of metastatic renal Cell carcinoma. A Hoosier Oncology Group trial.
- Management strategies and outcomes of germ Cell tumor patients with very high human chorionic gonadotropin levels.
- Hantavirus pulmonary syndrome in Indiana.
- Fatal hantavirus pulmonary syndrome in Indiana.
- Benign hematologic neoplasm associated with mediastinal mature teratoma in a patient with Klinefelter's syndrome: a case report.
- Reforming the community research program: from community clinical oncology program to the national Cancer institute community oncology research program.
Schools
Indiana University School Of Medicine
St Vincent Hospital
Indiana University Med Center
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- Fellow (FACP)
Education
-
Indiana University School of Medicine -
St Vincent Hospital and Health Care Center
Drug Facts
| NPI NUMBER | 1891799391 | |
| NPPES Provider LastName | ZON | |
| NPPES Provider FirstName | ROBIN | |
| NPPES Provider ZIPCode | 466011033 | |
| NPPES Provider State | IN | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 804.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 36.0 | |
| Percent Opioid Claims | 4.48 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1891799391 |
| Last Name Of The Provider | ZON |
| First Name Of The Provider | ROBIN |
| View All |
Similar Doctors
|
|
Dr. Richard C. Buck, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rafat H. Ansari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Taber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald H. Kawauchi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dean Park, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rudolph M. Navari, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Muhammad H. Isa, MD |
|
|
Dr. Lowell D. Smith, MD |